Industry-backed trials are positive

Share this article:
An analysis of studies registered on ClinicalTrials.gov showed those funded by industry were more apt to show positive outcomes but less apt to be published shortly after completion than trials funded by other sources.

Out of 546 trials, noted researchers writing in Annals of Internal Medicine, industry-funded trials reported positive outcomes in 85% of publications vs. 50% for government-funded trials, and 72% for nonprofits or non-federal organization-funded trials. The rate of publication within two years of study completion ranged from 32% among industry-funded trials to 56% among nonprofit or nonfederal organization–funded trials without industry contributions.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what ...

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...